Google Chrome
Safari
Firefox
Edge
Devices
Hovione offers simple, patented and globally competitive dry powder inhalers – Disposable, Capsule, Blister and Large Dose DPIs – which are available for fully integrated turn-key development with formulation and for licensing.
Search
Press Release / Sep 11, 2013
Hovione: EPO grants a new inhaler patent
Article / Sep 24, 2024
Formulating Inhaled Medicines
Excipient and delivery device selection play crucial roles in the formulation of inhaled drugs.
Article / Sep 10, 2019
Inhalation Drug Delivery: The Impact of Particle Size Reduction
Pharmaceutical Technology, September 2, 2019
Press Clipping / Apr 16, 2020
Hovione’s Inhaler for High-Dose Delivery Earns Product Design Award
Drug Development & Delivery, April 16, 2020
API
Hovione inhalation grade APIs bring unique controlled performance to your formulation.
Article / Nov 01, 2019
Hovione Technology: Dry powder inhalers towards effective affordable sustainable respiratory healthcare
On Drug Delivery, November 2019
Sunriser® DPI
High Performance, High-Dose Capsule DPI.
Article / Apr 01, 2007
Hovione Licenses Inhaler Technology to Sankyo & Biota
Drug Delivery Technology, April 2007
Press Release / Apr 07, 2014